Yu Hojun, Wilson Stephanie R
Department of Diagnostic Imaging, University of Calgary, Calgary, AB, Canada.
Ultrasound Q. 2011 Dec;27(4):217-23. doi: 10.1097/RUQ.0b013e318239422e.
The objective of the study was to determine the performance of Acoustic Radiation Force Impulse (ARFI) imaging to differentiate benign from malignant liver masses, both of hepatocellular origin and metastases, by quantification of their stiffness.
This study has institutional review board approval and informed consent. Eighty-nine patients (42 female and 47 male patients) with 105 liver masses had ARFI evaluation on ultrasound, S2000 (Siemens, Mountain View, Calif). Mean age of the patients was 53.67 years (range, 27-83 years). Mean diameter of the masses was 2.77 cm (range, 1.0-13.0 cm). Final diagnoses, confirmed by imaging on contrast-enhanced computed tomography, magnetic resonance, or ultrasound or biopsy, include hepatocellular carcinoma (n = 28), metastasis (n = 13), hemangioma (n = 35), focal nodular hyperplasia (n = 15), focal fat sparing (n = 8), focal fat deposit (n = 4), and adenoma (n = 2). Receiver operating characteristic analysis was performed to evaluate the diagnostic accuracy of the ARFI measurement and to extract the optimal cutoff values in the differentiation of benign from malignant disease.
Acoustic Radiation Force Impulse values showed a statistically significant difference between benign (1.73 [SD, 0.8] m/sec) and malignant masses (2.57 [SD, 1.01] m/sec) (P < 0.001). However, the area under the receiver operating characteristic curve was 0.744, suggesting only fair accuracy. For differentiation of malignant from benign masses, the sensitivity, specificity, positive predictive value, and negative predictive value were 68% (28/41), 69% (44/64), 58% (28/48), and 77% (44/57), respectively, when 1.9 m/sec was chosen as a cutoff value, reflective of a wide variation of ARFI values in each diagnosis. For differentiation of metastasis from benign masses, sensitivity, specificity, positive predictive value, and NPV were 69% (9/13), 89% (57/64), 56% (9/16), and 93% (57/61), respectively, when 2.72 m/sec was chosen as a cutoff value.
Acoustic Radiation Force Impulse measurement may be helpful to differentiate benign masses from metastases, in particular. Otherwise, ARFI measurements alone do not differentiate benign and malignant masses because of variations in stiffness of all types of masses.
本研究的目的是通过对肝肿块硬度的量化,确定声辐射力脉冲(ARFI)成像在鉴别肝细胞源性和转移性肝肿块的良恶性方面的性能。
本研究获得了机构审查委员会的批准并取得了知情同意。89例(42例女性和47例男性)患有105个肝肿块的患者接受了超声S2000(西门子,加利福尼亚州山景城)的ARFI评估。患者的平均年龄为53.67岁(范围27 - 83岁)。肿块的平均直径为2.77 cm(范围1.0 - 13.0 cm)。最终诊断通过增强计算机断层扫描、磁共振成像、超声成像或活检确定,包括肝细胞癌(n = 28)、转移瘤(n = 13)、血管瘤(n = 35)、局灶性结节性增生(n = 15)、局灶性脂肪缺失(n = 8)、局灶性脂肪沉积(n = 4)和腺瘤(n = 2)。进行了受试者操作特征分析,以评估ARFI测量的诊断准确性,并提取鉴别良恶性疾病的最佳临界值。
声辐射力脉冲值在良性肿块(1.73 [标准差,0.8] m/秒)和恶性肿块(2.57 [标准差,1.01] m/秒)之间显示出统计学上的显著差异(P < 0.001)。然而,受试者操作特征曲线下面积为0.744,表明准确性一般。对于鉴别恶性肿块与良性肿块,当选择1.9 m/秒作为临界值时,敏感性、特异性、阳性预测值和阴性预测值分别为68%(28/41)、69%(44/64)、58%(28/48)和77%(44/57),这反映了每种诊断中ARFI值的广泛变化。对于鉴别转移瘤与良性肿块,当选择2.72 m/秒作为临界值时,敏感性、特异性、阳性预测值和阴性预测值分别为69%(9/13)、89%(57/64)、56%(9/16)和93%(57/61)。
声辐射力脉冲测量可能有助于特别是鉴别良性肿块与转移瘤。否则,由于所有类型肿块硬度的变化,单独的ARFI测量不能鉴别良性和恶性肿块。